Recombinant multi-species TBK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TBK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]
The Alternative Names of target: 1200008B05Rik,AIARV,FTDALS4,IIAE8,NAK,NF-kappa-B-activating kinase,Serine/threonine-protein kinase TBK1,T2K,TANK-binding kinase 1,TBK1,Tbk1
Go
to TBK1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T63024-Ag-1/ GM-Tg-hg-T63024-Ag-2 | Human TBK1 protein | Human |
| GM-Tg-rg-T63024-Ag-1/ GM-Tg-rg-T63024-Ag-2 | Rat TBK1 protein | Rat |
| GM-Tg-mg-T63024-Ag-1/ GM-Tg-mg-T63024-Ag-2 | Mouse TBK1 protein | Mouse |
| GM-Tg-cynog-T63024-Ag-1/ GM-Tg-cynog-T63024-Ag-2 | Cynomolgus/Rhesus macaque TBK1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T63024-Ag-1/ GM-Tg-felg-T63024-Ag-2 | Feline TBK1 protein | Feline |
| GM-Tg-cang-T63024-Ag-1/ GM-Tg-cang-T63024-Ag-2 | Canine TBK1 protein | Canine |
| GM-Tg-bovg-T63024-Ag-1/ GM-Tg-bovg-T63024-Ag-2 | Bovine TBK1 protein | Bovine |
| GM-Tg-equg-T63024-Ag-1/ GM-Tg-equg-T63024-Ag-2 | Equine TBK1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T63024-Ag-1/ GM-Tg-hg-T63024-Ag-2;
GM-Tg-rg-T63024-Ag-1/ GM-Tg-rg-T63024-Ag-2;
GM-Tg-mg-T63024-Ag-1/ GM-Tg-mg-T63024-Ag-2; GM-Tg-cynog-T63024-Ag-1/ GM-Tg-cynog-T63024-Ag-2; GM-Tg-felg-T63024-Ag-1/ GM-Tg-felg-T63024-Ag-2; GM-Tg-cang-T63024-Ag-1/ GM-Tg-cang-T63024-Ag-2; GM-Tg-bovg-T63024-Ag-1/ GM-Tg-bovg-T63024-Ag-2; GM-Tg-equg-T63024-Ag-1/ GM-Tg-equg-T63024-Ag-2 |
| Products Name | TBK1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TBK1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TBK1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.